February 9, 2016
15,507
90
5
0.61%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
2:04Now PlayingA company that markets what would be a revolutionary test for detecting cancer has become the focus of a CBS News investigation that asks: Can these claims possibly be true? In a report by CBS, correspondent Jim Axelrod found, Pathway Genomics, who says its so-called "liquid biopsy" is able to accomplish what others say is years away. While Pathway Genomics cites the cancer research of Dr. Max Diehn as evidence, Diehn says the tests likely can't do what they promise. #InsideEdition
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.